EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Use of the Omnipod 5 Automated Insulin Delivery System Activity Feature Reduces Insulin Delivery and Attenuates the Drop in Glycemia Associated With Exercise in a Randomized Controlled Trial

Lauren V Turner, Jennifer L Sherr, Dessi P Zaharieva, Jesica Baran, Irl B Hirsch iD, Bruce W Bode, Sue A Brown, Suzan Bzdick, Mei Mei Church, David W Hansen, Ryan Kingman, Lori M Laffel und 8 weitere

Diabetes Care · 2025

DOI: 10.2337/dc25-0141 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Diabetes Care, 2025. Verfasst von Lauren V Turner und 19 weiteren Autor:innen. Beteiligte Einrichtung: School of Kinesiology and Health Science, York University, Toronto, Canada. Hauptthemen laut MEDLINE: Insulin, Exercise, Blood Glucose, Diabetes Mellitus, Type 1. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, Insulet Corporation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE To compare the efficacy of enabling Activity feature 60 (AF-60) or 30 min (AF-30) before prolonged exercise versus the automated mode (Auto) in adults and adolescents with type 1 diabetes wearing the Omnipod 5 System. RESEARCH DESIGN AND METHODS In this three-way crossover study, 38 participants (age 30 ± 15 years; BMI 24.7 ± 4.1 kg/m2; HbA1c 7.5% ± 0.9% [58 ± 11 mmol/mol]) from the extension phase of the pivotal trial of the Omnipod 5 System completed a 70-min treadmill session at 64–76% maximum heart rate in a postabsorptive state under each of the three conditions. Auto was resumed after exercise, and glycemia and insulin delivery metrics were examined in the 4-h postexercise period. RESULTS The percentage of participants who developed hypoglycemia during exercise did not differ significantly between Auto (42%) and AF-60 (29%; P = 0.34) or AF-30 (24%; P = 0.14). However, AF-60 and AF-30 reduced insulin delivery compared with Auto in the hour before (P < 0.001) and during exercise (P < 0.001). There was also a favorable attenuation in glucose drop during exercise when comparing Auto (−57 ± −35 mg/dL) with AF-60 (−44 ± −33 mg/dL; P = 0.02) and AF-30 (−36 ± −34 mg/dL; P = 0.01). In the postexercise period, glycemia and insulin delivery were comparable. CONCLUSIONS Enabling the Activity feature either 60 or 30 min before exercise reduced insulin delivery and attenuated glucose drops relative to Auto, but hypoglycemia incidence was not different across the three conditions. These findings support the use of the Omnipod 5 System for exercise but highlight the importance of using additional strategies, such as earlier use of Activity feature and/or carbohydrate intake to further reduce hypoglycemia risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InsulinExerciseBlood GlucoseDiabetes Mellitus, Type 1Insulin Infusion SystemsHypoglycemic AgentsHumansAdultMaleFemaleCross-Over StudiesAdolescentYoung Adult

Substanzen

InsulinBlood GlucoseHypoglycemic Agents

Autor:innen und Institutionen

  • School of Kinesiology and Health Science, York University, Toronto, Canada.
  • Yale School of Medicine, New Haven, CT.
  • Division of Pediatric Endocrinology, Department of Pediatrics, Stanford University, Stanford, CA.
  • University of Washington, Seattle, WA.
  • Atlanta Diabetes Associates, Atlanta, GA.
  • Center for Diabetes Technology, Division of Endocrinology, University of Virginia, Charlottesville, VA.

ORCID-Profile: Irl B Hirsch, Michael C Riddell

Förderung

  • NIDDK NIH HHS
  • Insulet Corporation

Zitieren

APA

Turner, L. V., Sherr, J. L., Zaharieva, D. P., Baran, J., Hirsch, I. B., Bode, B. W., Brown, S. A., Bzdick, S., Church, M. M., Hansen, D. W., Kingman, R., Laffel, L. M., Shah, V. N., Stone, S., Vienneau, T. E., Huyett, L. M., Dumais, B., Ly, T. T., Riddell, M. C., & Omnipod 5 Exercise Research Group (2025). Use of the Omnipod 5 Automated Insulin Delivery System Activity Feature Reduces Insulin Delivery and Attenuates the Drop in Glycemia Associated With Exercise in a Randomized Controlled Trial. Diabetes Care. https://doi.org/10.2337/dc25-0141

Vancouver

Turner LV, Sherr JL, Zaharieva DP, Baran J, Hirsch IB, Bode BW, et al. Use of the Omnipod 5 Automated Insulin Delivery System Activity Feature Reduces Insulin Delivery and Attenuates the Drop in Glycemia Associated With Exercise in a Randomized Controlled Trial. Diabetes Care. 2025. doi:10.2337/dc25-0141

BibTeX
@article{Turner2025,
  author = {Turner, Lauren V and Sherr, Jennifer L and Zaharieva, Dessi P and Baran, Jesica and Hirsch, Irl B and Bode, Bruce W and Brown, Sue A and Bzdick, Suzan and Church, Mei Mei and Hansen, David W and Kingman, Ryan and Laffel, Lori M and Shah, Viral N and Stone, Sheri and Vienneau, Todd E and Huyett, Lauren M and Dumais, Bonnie and Ly, Trang T and Riddell, Michael C and Omnipod 5 Exercise Research Group, Omnipod 5 Exercise Research Group},
  title = {Use of the Omnipod 5 Automated Insulin Delivery System Activity Feature Reduces Insulin Delivery and Attenuates the Drop in Glycemia Associated With Exercise in a Randomized Controlled Trial},
  journal = {Diabetes Care},
  year = {2025},
  doi = {10.2337/dc25-0141}
}
Kostenlos starten →